Plasmodium falciparum MORC protein modulates gene expression through interaction with heterochromatin

  1. Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
  2. Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, United States
  3. Huck Institutes Center for Eukaryotic Gene Regulation, Pennsylvania State University, University Park, Pennsylvania, United States
  4. Huck Institutes Center for Malaria Research, Pennsylvania State University, University Park, Pennsylvania, United States
  5. Hospital AC Camargo, Centro Internacional de Pesquisa, São Paulo, Brazil
  6. Department of Parasitology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil
  7. School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC 3083, Australia
  8. Department of Chemistry, Pennsylvania State University, University Park, Pennsylvania, United States

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a response from the authors (if available).

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Sebastian Lourido
    Whitehead Institute for Biomedical Research, Cambridge, United States of America
  • Senior Editor
    Dominique Soldati-Favre
    University of Geneva, Geneva, Switzerland

Reviewer #1 (Public Review):

Summary: The study provides valuable insights into the role of PfMORC in Plasmodium's epigenetic regulation, backed by a comprehensive methodological approach. The overarching goal was to understand the role of PfMORC in epigenetic regulation during asexual blood stage development, particularly its interactions with ApiAP2 TFs and its potential involvement in the regulation of genes vital for Plasmodium virulence. To achieve this, they conducted various analyses. These include a proteomic analysis to identify nuclear proteins interacting with PfMORC, a study to determine the genome-wide localization of PfMORC at multiple developmental stages, and a transcriptomic analysis in PfMORCHA-glmS knockdown parasites. Taken together, this study suggests that PfMORC is involved in chromatin assemblies that contribute to the epigenetic modulation of transcription during the asexual blood stage development.

Strengths: The study employed a multi-faceted approach, combining proteomic, genomic, and transcriptomic analyses, providing a holistic view of PfMORC's role. The proteomic analysis successfully identified several nuclear proteins that may interact with PfMORC. The genome-wide localization offered valuable insights into PfMORC's function, especially its predominant recruitment to subtelomeric regions. The results align with previous findings on PfMORC's interaction with ApiAP2 TFs. Notably, the authors meticulously contextualized their findings with prior research, including pre-prints, adding credibility to their work.

Weaknesses: While the study identifies potential interacting partners and loci of binding, direct functional outcomes of these interactions remain an inference. The authors heavily rely on past research for some of their claims. While it strengthens some assertions, it might indicate a lack of direct evidence in the current study for particular aspects. The declaration that PfMORC may serve as an attractive drug target is substantial. While the data suggests its involvement in essential processes, further studies are required to validate its feasibility as a drug target.

Reviewer #2 (Public Review):

Summary:
This is a paper entitled "Plasmodium falciparum MORC protein modulates gene expression through interaction with heterochromatin" describes the role of PfMORC during the intra-erythrocytic cycle of Plasmodium falciparum. Garcia et al. investigated the PfMORC-interacting proteins and PfMORC genomic distribution in trophozoites and schizonts. They also examined the transcriptome of the parasites after partial knockdown of the transcript.

Strengths:
This study is a significant advance in the knowledge of the role of PfMORC in heterochromatin assembly. It provides an in-depth analysis of the PfMORC genomic localisation and its correlation with other chromatin marks and ApiAP2 transcription factor binding.

Weaknesses:
However, most of the conclusions are based on the function of interacting proteins and the genomic localisation of the protein. The authors did not investigate the direct effects of PfMORC depletion on heterochromatin marks. Furthermore, the results of the transcriptomic analysis are puzzling as 50% of the transcripts are downregulated, a phenotype not expected for a heterochromatin marker.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation